You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Printed Wideband Metamaterial Antennas for Ballistic Panels

    SBC: APPLIED NANOTECH, INC.            Topic: N10AT021

    The U.S. Navy has initiated a program to develop the next-generation Joint Counter Radio Controlled Improvised Explosive Device Electronic Warfare (JCREW) 3.3 system to detect and jam enemy improvised explosive devices (IEDs). The objective of this propos

    STTR Phase II 2013 Department of DefenseNavy
  2. Noninvasive Neural Stimulation Technology

    SBC: HIGHLAND INSTRUMENTS INC            Topic: 102

    DESCRIPTION provided by applicant The past decade has seen a rapid increase in the application of brain stimulation devices to treat a variety of movement disorders such as Parkinsonandapos s disease PD and other neuropathologies Present noninvasive brain stimulation technologies suffer from fundamental limitations and have yet to reach the level of efficacy of invasive methods such as de ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  3. PillStream: Agile High-Throughput Assembly of Custom Multi-Medication Packaging

    SBC: ARTAIC, LLC            Topic: NINR

    DESCRIPTION provided by applicant Errors in the administration of medications to residents of long term care facilities LTCFs threaten resident safety and add significant unnecessary costs to the healthcare system Use of unit dose medications that require LTCF staff to manually sort and assemble specific patient medications times per day can result in error rates as high as with of total errors ha ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Miniature Stabilized Gimbal Laser Pointing System

    SBC: Ascendant Engineering Solutions, LLC            Topic: AF112097

    ABSTRACT: Ascendant Engineering Solutions (AES) proposes to build upon the modeling and analysis and conceptual design effort from the execution of its Phase I contract to develop a flight-worthy form-fit-function Key Technology Demonstrator system during a Phase II contract. The primary objectives are to: 1) Precisely point and hold a laser spot on a target; 2) Safely control the laser beam to p ...

    SBIR Phase II 2013 Department of DefenseAir Force
  5. Closed-Loop Wireless Optical Neuromodulation for Motion Disorders

    SBC: FERRO SOLUTIONS, INC.            Topic: NINDS

    DESCRIPTION provided by applicant Optogenetic tools for activating and silencing specific neurons embedded within dense brain networks in a temporally precise fashion using light are key to understanding the roles that specific neurons play in behavior neural computation and disease In our Phase I SBIR Ferro Solutions and the Boyden lab at MIT collaborated to develop a fully wirelessly powered and ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Novel Antithrombotic Diadenosine Tetraphosphate Analogs

    SBC: GLSynthesis Inc.            Topic: 100

    DESCRIPTION Undesired platelet activation can be result of many common pathologies or interventions Arterial thrombosis and the acute ischemic events that follow such as myocardial infarction and stroke are among the leading causes of death incapacitation and rising health care costs in the developed world Therefore antiplatelet drugs have significant market share and clinical importance ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  7. A new radiopharmaceutical for the treatment of metastatic bone cancer

    SBC: IsoTherapeutics Group LLC            Topic: NCI

    DESCRIPTION provided by applicant There are roughly new cases of metastatic cancer to the skeleton in the U S each year andquot Bone seekingandquot radiopharmaceuticals are used for bone pain palliation and have shown promise for treating bone metastases They typically combine a radioactive metal such as samarium with a chelant The chelant part of the molecule is taken up by gr ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Narrow-spectrum Agents Acting against Helicobacter pylori

    SBC: ARIETIS CORPORATION            Topic: NIAID

    DESCRIPTION provided by applicant The goal of this project is to develop a therapeutic acting specifically against Helicobacter pylori the causative agent of peptic ulcer and gastric carcinoma Roughly every other person carries the pathogen and there are an estimated cases annually of active infection in the US The currently used triple therapy is a combination of a proton pump inhibitor and broad ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Biomarker Quantitation by NP-MS Tissue Imaging.

    SBC: IONWERKS INC            Topic: NIDA

    DESCRIPTION provided by applicant MALDI tissue imaging when enabled by Nanoparticulate NP Matrix implantation is maturing into a useful preclinical tool for biomarker and drug discovery in our laboratory and at NIDA IRP Quantitatively reproducible images from serial coronal sections suggest that relative quantitation is now possible in rodent models of disease and injury Nanoparticulate ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Long-Acting G-CSF Analog for Treating ARS

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: NIAID

    DESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government